Two Sigma Advisers’s Enzo Biochem, Inc. ENZ Stock Holding History

Two Sigma Advisers’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-51,000	Closed	-$164K	–	2948
2021 Q4	$164K	Sell	51,000 -142,100	-74%	-$485K	﹤0.01%	2339
2021 Q3	$684K	Buy	193,100 +158,600	+460%	+$529K	﹤0.01%	1790
2021 Q2	$109K	Buy	+34,500	New	+$109K	﹤0.01%	2336
2020 Q3	–	Sell	-63,000	Closed	-$141K	–	2664
2020 Q2	$141K	Sell	63,000 -19,957	-24%	-$51.3K	﹤0.01%	2315
2020 Q1	$210K	Sell	82,957 -21,100	-20%	-$51.8K	﹤0.01%	2151
2019 Q4	$274K	Sell	104,057 -18,200	-15%	-$54.4K	﹤0.01%	2094
2019 Q3	$440K	Buy	122,257 +36,300	+42%	+$128K	﹤0.01%	1770
2019 Q2	$290K	Sell	85,957 -6,800	-7%	-$24K	﹤0.01%	2021
2019 Q1	$253K	Sell	92,757 -5,000	-5%	-$16.4K	﹤0.01%	2046
2018 Q4	$272K	Sell	97,757 -8,816	-8%	-$28.9K	﹤0.01%	2026
2018 Q3	$439K	Buy	106,573 +2,500	+2%	+$11.4K	﹤0.01%	1844
2018 Q2	$540K	Buy	104,073 +2,600	+3%	+$15.8K	﹤0.01%	1885
2018 Q1	$556K	Hold	101,473	–	–	﹤0.01%	1771
2017 Q4	$827K	Sell	101,473 -41,385	-29%	-$395K	﹤0.01%	1590
2017 Q3	$1.5M	Sell	142,858 -26,415	-16%	-$293K	﹤0.01%	1341
2017 Q2	$1.87M	Buy	169,273 +7,664	+5%	+$71.4K	0.01%	1237
2017 Q1	$1.35M	Buy	161,609 +12,004	+8%	+$84.6K	﹤0.01%	1440
2016 Q4	$1.04M	Buy	149,605 +9,705	+7%	+$61.9K	﹤0.01%	1538
2016 Q3	$712K	Sell	139,900 -24,700	-15%	-$148K	﹤0.01%	1509
2016 Q2	$983K	Buy	164,600 +101,200	+160%	+$562K	0.01%	1173
2016 Q1	$288K	Buy	63,400 +42,900	+209%	+$191K	﹤0.01%	1690
2015 Q4	$92K	Buy	+20,500	New	+$86.6K	﹤0.01%	1778
2014 Q1	–	Sell	-29,800	Closed	-$88K	–	2590
2013 Q4	$88K	Buy	+29,800	New	+$73.9K	﹤0.01%	2219

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCA

VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

Two Sigma Advisers's ENZ Position: Q1 2022 in Review

Two Sigma Advisers sold out of Enzo Biochem, Inc. (ENZ) in Q1 2022, closing a stake of 51,000 shares — an estimated $164K sold.

Two Sigma Advisers first reported a position in ENZ in Q4 2013 and held it in 23 quarters. The position peaked at $1.87M in Q2 2017. 51 funds tracked by Wall St. Rank hold ENZ as of Q1 2022.

Two Sigma Advisers reported no remaining Enzo Biochem, Inc. position as of Q1 2022 after selling out during the quarter.
Two Sigma Advisers sold 51,000 Enzo Biochem, Inc. shares in Q1 2022, an estimated $164K.
Two Sigma Advisers first reported a position in Enzo Biochem, Inc. in Q4 2013 and held it in 23 quarters.
Two Sigma Advisers's Enzo Biochem, Inc. position peaked at $1.87M in Q2 2017.
51 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.